Gastrointestinal glycocalyx and mucus layer (GI mucus barrier)

The gastrointestinal glycocalyx and mucus layer constitute a complex, multi-layered anionic barrier that coats the epithelial surface of the digestive tract (Johansson et al., 2011). This structure is primarily composed of membrane-bound glycoproteins and secreted gel-forming mucins, such as MUC2, which provide a physical and chemical shield against mechanical stress, digestive enzymes, and pathogens (Bansil & Turner, 2018). The anionic nature of this layer, derived from sialic acid and sulfate groups, plays a critical role in regulating the diffusion of ions and molecules while facilitating the adhesion of beneficial microbiota (Cone, 2009). In diseases like ulcerative colitis or peptic ulcers, the integrity of this layer is compromised, leading to inflammation and tissue damage (Pelaseyed et al., 2014). Pharmacologically, this layer is targeted by mucoadhesive delivery systems to prolong drug residence time and by cytoprotective agents like sucralfate that reinforce the barrier (Khutoryanskiy, 2011). Additionally, mucolytic agents like N-acetylcysteine are used to modify the viscosity of this layer in conditions where mucus hypersecretion occurs (Malerba & Ragnoli, 2008). Understanding the electrostatic and steric properties of this barrier is essential for optimizing oral drug bioavailability and developing treatments for mucosal inflammatory disorders (Ensign et al., 2012).

Other names

Intestinal mucus layerGI mucosal barrierAnionic glycocalyxMucin layerGastrointestinal glycocalyx

Drugs interact with this target through mucoadhesion, electrostatic binding to anionic sites, or enzymatic/chemical degradation of mucin fibers to alter permeability and provide mucosal protection.